Orange Book product · Brand (NDA)
KHINDIVI
HYDROCORTISONE
At a glance
May 28, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 28, 2025
1 yr 1 mo ago
Today
Patent 11904046 expires
Listed drug product patent expiration.
Feb 23, 2043
in 16 yr 11 mo
Patent 12133914 expires
Listed method-of-use patent (U-4215) expiration.
Feb 23, 2043
in 16 yr 11 mo
Pharmaceutical detail
Active ingredient
HYDROCORTISONE
Strength
1MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 218980
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —CORT-DOMEBrand (NDA)
NDA 009585 · BAYER PHARMS
- 2018HYDROCORTISONEGeneric (ANDA)
ANDA 203810 · ENCUBE
- 2016ALA-CORTGeneric (ANDA)
ANDA 080706 · CROWN LABS
- 2010HYDROCORTISONEGeneric (ANDA)
ANDA 040879 · RISING
- 2004HYDROCORTISONEGeneric (ANDA)
ANDA 040503 · CHARTWELL MOLECULAR
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089273 · TOPIDERM
- 1989HYDROCORTISONEGeneric (ANDA)
ANDA 089754 · ALPHARMA US PHARMS
- 1988NOGENIC HCGeneric (ANDA)
ANDA 087427 · IVAX PHARMS
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089682 · ACTAVIS MID ATLANTIC
- 1988HYDROCORTISONEGeneric (ANDA)
ANDA 089706 · NASKA
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089414 · FOUGERA PHARMS INC
- 1986HYDROCORTISONEGeneric (ANDA)
ANDA 089413 · PHARMADERM
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11904046 | Feb 23, 2043 | in 16 yr 11 mo | ProductU-4216 |
| 12133914 | Feb 23, 2043 | in 16 yr 11 mo | U-4215 |

